Aims of the innovative medicines initiative

The Innovative Medicine Initiative (IMI) is one of the flagships of health research under Horizon 2020, the current framework programme for research and innovation.

IMI is a Joint Undertaking between the European Union, represented by the Commission, and the European Federation of Pharmaceutical Industries and Associations.

Other industries and partners can join, either as members or as associated partners.

Goals of the IMI

IMI's strategic research agenda is aligned with the priorities of the World Health Organization's 2013 report, Priority medicines for Europe and the world.

The main goal is to speed up the development of better and safer medicines with specific objectives such as

  • increasing the success rate of clinical trials of new medicines and vaccines
  • speeding up the earlier stages of drug development
  • developing new biological markers to diagnose diseases and assess treatments

IMI also aims to develop new treatments for areas with the greatest needs, and to improve the drug development process by creating tools to assess the efficacy, safety and quality of medicines.

Budget and focus

From 2008-2013, IMI had a total budget of close to €2 billion. From 2014-2024 its budget will reach €3.3 billion, half of which comes from Horizon 2020.

Currently IMI addresses the entire life science research and innovation value chain and actively involving life science industries other than pharmaceuticals, for example the vaccine, animal health and biomedical imaging industries.

To achieve its objectives, IMI is fostering the implementation of results through a tailor-made intellectual property policy.

Most importantly, IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. These projects bring together universities, industries, small and medium-sized enterprises (SMEs), patient organisations, and regulators.

Publications

Carrying the torch – IMI outputs and results

IMI Highlights 2017

IMI – Europe's partnership for health

Staff Working Document

Report on IMI Final Evaluation

Report on IMI2 Interim Evaluation

Latest